I was a little worried yesterday
by: the_donnbonn 12/02/05 10:21 am
Msg: 21889 of 21891
when some analysts had some positive things to say about the Berna deal. For the most part these guys have been saying negative things about Crucell since the share price was $2. Guess they don't like 10 baggers.
Things are looking brighter today.
Goldman Sachs:
Goldman Says Crucell Overpays For Berna
Friday, December 02, 2005 5:37:18 AM ET
Dow Jones Newswires
0920 GMT [Dow Jones] Goldman Sachs says Crucell (CRXL) is overpaying for Berna Biotech (BBIN.EB) and is doing so with over-valued equity. On Thursday, Crucell launched an EUR381M bid for Berna. Goldman sees counterbid highly unlikely. Berna Biotech is loss-making and "requires significant restructuring to make it a viable, sustainable business." Remains skeptical that Crucell, an R&D based company, can accelerate sales of Berna's products. Rates underperform. Shares +0.2% at EUR21.75. (STS)
ING:
Crucell Buy Offers Limited Synergies - ING
Friday, December 02, 2005 8:52:32 AM ET
Dow Jones Newswires
1241 GMT [Dow Jones] Crucell's (35856.AE) planned takeover of Berna Biotech (BBIN.EB) won't yield significant synergies, says ING, but could be welcomed by Crucell shareholders as it locks in additional value. Turning Berna operationally around could prove quite a challenge, and require a lot of time for Crucell's management. Maintains sell rating, EUR11 price target. Shares -0.9% at EUR21.50. (NSP)
Looks like we're back on track again.